Shashikant Srivastava

26PUBLICATIONS
26CO-AUTHORS
Dental therapeutics, pharmacology and toxicologyMedical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Medical bacteriologyHost-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 12, 2026
A point-of-care saliva-based therapeutic drug monitoring tool for levofloxacin and linezolid.

|Apr 21, 2026
Systematic and quantitative analyses of hollow fiber model of Mycobacterium abscessus lung disease studies and new dosing recommendations.

|Apr 10, 2026
Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions.

Shashikant Srivastava, Sanjay Singh, Gunavanthi D Boorgula

|Apr 09, 2026
Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease.

Sanjay Singh, Avneesh Shrivastava, Gunavanthi D Boorgula

|Mar 05, 2026
Do we need to revise the dose of isoniazid for the treatment of tuberculosis in children?

Jan-Willem C Alffenaar, Shashikant Srivastava, Rosella Centis

|Dec 19, 2025
Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.

Tawanda Gumbo, Gunavanthi D Boorgula, Shashikant Srivastava

Pageof 5

Frequent Collaborators

16 joint publications

Tawanda Gumbo

11 joint publications

Sanjay Singh

2 joint publications

Jann-Yuan Wang

2 joint publications

Megan Devine